Related Experiment Video

Updated: Jun 2, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
03:45

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

Published on: August 8, 2022

Molecular biology of heart disease

Robert Roberts1

  • 1Robert Roberts, Ruddy Canadian Cardiovascular Genetics Centre, University of Ottawa Heart Institute, 40 Ruskin Street, Ottawa, Ontario, K1Y 4W7, Canada. rroberts@ottawaheart.ca

World Journal of Cardiology
|April 29, 2011
PubMed

Insights

Dr. Robert Roberts pioneered molecular cardiology, identifying over 20 genes for cardiovascular disorders. His work led to the first genetic variant for coronary artery disease (CAD) and 13 novel CAD genes.

Area of Science:

  • Cardiovascular Genetics
  • Molecular Cardiology
  • Genetics of Cardiomyopathies

Background:

  • Dr. Roberts' early work in cardiac enzymology led to the MBCK test, a standard for myocardial infarction diagnosis for over 30 years.
  • He transitioned to molecular biology and genetics of cardiomyopathies in the late 1970s.
  • He is recognized as a founder of molecular cardiology.

Purpose of the Study:

  • To identify genes predisposing to coronary artery disease (CAD) and myocardial infarction.
  • To advance the understanding of genetic factors in cardiovascular disorders.

Main Methods:

  • Genome-wide association studies (GWAS).
  • Gene sequencing and identification.
  • Collaborative research with international consortia like CARDIoGRAM.

Main Results:

  • Identified and sequenced over 20 genes responsible for cardiovascular disorders.
  • Discovered the first genetic variant for CAD, 9p21.
  • In collaboration, identified 13 novel genes associated with CAD.

Conclusions:

  • Dr. Roberts' research has significantly advanced the field of cardiovascular genetics.
  • His work has identified key genetic contributors to CAD and myocardial infarction.
  • The identified genes provide targets for future research and potential therapeutic strategies.

Keywords:
Creatine kinaseGenetic linkageGeneticsGenome wide association studiesHeart diseaseMolecular biology

Related Concept Videos

Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...